Queen Mary University of London spin-out Retroscreen Virology places 12,293,077 ordinary shares.
Retroscreen Virology, a life sciences spin-out of Queen Mary University of London, has raised a conditional £33.6m ($56m) before expenses and £32.8m after expenses ($54.71m). The company placed 12,923,077 ordinary shares at £2.60 ($4.33) each, which were purchased by both existing and new investors.
Retroscreen is working on the next generation of antiviral drugs and vaccines. It plans to use the money to accelerate its biomarker discovery programme focused on flu and asthma. It will also refine its asthma model…
